J. Lasky

发表

Detecting Splicing Variants in Idiopathic Pulmonary Fibrosis from Non-Differentially Expressed Genes

Nan Deng, Dongxiao Zhu, D. Zhu, 2013, PloS one.

Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.

J. Lasky, B. Shan, Weichao Guo, 2009, American journal of physiology. Lung cellular and molecular physiology.

Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19

J. Lasky, R. Lanier, J. Fuloria, 2020, Advances in Therapy.

American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

Takeshi Johkoh, Holger J Schünemann, David A Lynch, 2011 .

HDAC8 inhibition ameliorates pulmonary fibrosis.

Y. Zhuang, Takayoshi Suzuki, J. Lasky, 2019, American journal of physiology. Lung cellular and molecular physiology.

Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice.

W. Banks, J. Lasky, L. Ortiz, 1999, American journal of respiratory cell and molecular biology.

Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1.

M. Beasley, J. Lasky, L. Ortiz, 2002, American journal of physiology. Lung cellular and molecular physiology.

Silica-induced apoptosis in murine macrophage: involvement of tumor necrosis factor-alpha and nuclear factor-kappaB activation.

J. Lasky, L. Ortiz, M. Friedman, 2002, American journal of respiratory cell and molecular biology.

Tumor Necrosis Factor Receptor Deficiency Protects Mice From Silica-Induced Lung Fibrosis by Altering Lung Matrix Metalloproteinase-13/Tissue Inhibitor of Metalloproteinase-1 RNA Expression and Decreasing Activating Protein-1 Activation

M. Selman, A. Pardo, J. Lasky, 2001 .

Exacerbation of bleomycin-induced lung injury in mice by amifostine.

J. Lasky, L. Ortiz, M. Friedman, 1999, American journal of physiology. Lung cellular and molecular physiology.

Antifibrotic therapy for the treatment of pulmonary fibrosis.

J. Lasky, L. Ortiz, L. A. Ortiz, 2001, The American journal of the medical sciences.

Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis

L. Richeldi, J. Lasky, M. Demedts, 2015, Respiratory Research.

The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.

Takashi Takahashi, J. Lasky, B. Shan, 2011, American journal of respiratory cell and molecular biology.

Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.

J. Lasky, P. Kadowitz, G. F. Lasker, 2013, American journal of physiology. Heart and circulatory physiology.

Hospitalizations in patients with idiopathic pulmonary fibrosis

Hyun J. Kim, I. Noth, M. Strek, 2021, Respiratory Research.

Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.

J. Lasky, B. Shan, E. Flemington, 2011, Virology.

CONNECTIVE TISSUE GROWTH FACTOR

J. Lasky, 2006 .

TGF-β1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts.

Y. Zhuang, C. Sánchez, J. Lasky, 2017, American journal of physiology. Lung cellular and molecular physiology.

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.

D. Schroeder, J. Lasky, C. Daniels, 2010, American journal of respiratory and critical care medicine.

Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

W. Banks, J. Lasky, L. Ortiz, 1998, Experimental lung research.

A 32-year-old man with recurrent kidney stones and an abnormal chest radiograph.

F. Simeone, J. Lasky, R. Shackelford, 2011, Chest.

Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats.

J. Lasky, G. Morris, J. Y. Liu, 1997, American journal of respiratory cell and molecular biology.

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort

I. Noth, K. Flaherty, J. Lasky, 2022, Lung.

A Phase II Clinical Trial of Low‐Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis

H. Collard, F. Martinez, I. Noth, 2018, Chest.

Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective.

Y. Kondoh, J. Lasky, K. Hagiwara, 2018, Respiratory investigation.

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis

C. Ruppert, W. Seeger, S. Pullamsetti, 2018, PloS one.

Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.

S. Nathan, J. Lasky, T. Tran, 2015, American journal of respiratory and critical care medicine.

Carcinogenic effects of oil dispersants: A KEGG pathway-based RNA-seq study of human airway epithelial cells.

Yao-Zhong Liu, J. Lasky, Guangdi Wang, 2017, Gene.

Transforming Growth Factor-β1 Induces Heparan Sulfate 6-O-Endosulfatase 1 Expression in Vitro and in Vivo*

Dawn R. Chin, J. Lasky, X. Yue, 2008, Journal of Biological Chemistry.

Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

S. Birring, M. Scholand, A. Russell, 2015, Current respiratory medicine reviews.

A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

G. Raghu, M. Scholand, C. Spino, 2022, medRxiv.

Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq

Y. Zhuang, N. Kaminski, J. Lasky, 2020, BMC Pulmonary Medicine.

INVITED REVIEW SERIES: PULMONARY FIBROSIS

J. Lasky, S. Mutsaers, R. Klingsberg, 2009 .

Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

J. Lasky, B. Shan, G. Morris, 2010, American journal of physiology. Lung cellular and molecular physiology.

The effects of ethanol ingestion on the accuracy of pulmonary diffusing capacity measurement.

F. Simeone, J. Lasky, H. Glindmeyer, 2005, Chest.

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Y. Zhuang, J. Lasky, B. Shan, 2017, PloS one.

Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.

R. Johns, R. Chambers, G. Laurent, 2005, The American journal of pathology.

Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma

J. Lasky, E. Flemington, Zhen Lin, 2013, Virology Journal.

TGF-β: Titan of Lung Fibrogenesis.

J. Lasky, B. Shan, X. Yue, 2010, Current enzyme inhibition.

Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis.

J. Lasky, Ying Zhuo, Jian Zhang, 2004, American journal of physiology. Lung cellular and molecular physiology.

Differential expression of platelet-derived growth factor-α receptor by Thy-1- and Thy-1+ lung fibroblasts.

J. Lasky, J. Hagood, J. Mcintosh, 1999, American journal of physiology. Lung cellular and molecular physiology.

Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis.

J. Lasky, L. Ortiz, G. Hoyle, 1998, American journal of physiology. Lung cellular and molecular physiology.

Interleukins involved in the pathogenesis of chronic airway inflammation.

J. Lasky, A. Brody, 1997, Research in immunology.

Upregulation of the PDGF-alpha receptor precedes asbestos-induced lung fibrosis in rats.

J. Lasky, J. Y. Liu, A. Brody, 1998, American journal of respiratory and critical care medicine.

Chrysotile asbestos induces PDGF-A chain-dependent proliferation in human and rat lung fibroblasts in vitro.

J. Lasky, A. Brody, J. Bonner, 1996, Chest.

Chrysotile asbestos stimulates platelet-derived growth factor-AA production by rat lung fibroblasts in vitro: evidence for an autocrine loop.

L. Ostrowski, J. Lasky, A. Brody, 1995, American Journal of Respiratory Cell and Molecular Biology.

Activation of proMMP-2 and Src by HHV8 vGPCR in human pulmonary arterial endothelial cells.

J. Lasky, B. Shan, Ying Zhuo, 2007, Journal of molecular and cellular cardiology.

Dexamethasone activates expression of the PDGF-α receptor and induces lung fibroblast proliferation.

J. Lasky, A. Brody, M. Corti, 1998, American journal of physiology. Lung cellular and molecular physiology.

Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition*

J. Lasky, B. Shan, Ying Zhuo, 2008, Journal of Biological Chemistry.

Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension

J. Lasky, D. Prockop, Jeffrey L. Spees, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A 56-Year-Old-Man With Common Variable Immunodeficiency and Worsening Dyspnea.

J. Lasky, C. Limsuwat, P. Daroca, 2018, Chest.

Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis.

J. Lasky, L. Ortiz, G. Hoyle, 1998, The American journal of physiology.

Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.

W. Hellstrom, J. Lasky, P. Kadowitz, 2009, Journal of andrology.

Attenuation of Allergen, IL-13- and TGF-α-Induced Lung Fibrosis Following the Treatment of IL-15 in Mice.

A. Verma, J. Lasky, H. Kandikattu, 2019, American journal of respiratory cell and molecular biology.

Attenuation of Allergen-, IL-13 – , and TGF- a – induced Lung Fibrosis after the Treatment of rIL-15 in Mice Overexpression Protects against Lung Fibrosis

A. Verma, J. Lasky, H. Kandikattu, 2019 .

A critical role for IL-18 in transformation and maturation of naive eosinophils to pathogenic eosinophils.

J. Lasky, M. Manohar, U. Blecker, 2018, The Journal of allergy and clinical immunology.

Activation of transcription factor IL‐6 (NF‐IL‐6) and nuclear factor‐κB (NF‐κB) by lipid ozonation products is crucial to interleukin‐8 gene expression in human airway epithelial cells

J. Lasky, M. Friedman, W. A. Toscano, 2007, Environmental toxicology.

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.

G. Raghu, M. Scholand, J. Albayda, 2022, The Lancet. Respiratory medicine.

Novel mediators of idiopathic pulmonary fibrosis.

Santosh Kumar Yadav, J. Lasky, Brian Deskin, 2022, Clinical science.

A RANDOMIZED PLACEBO CONTROLLED TRIAL ASSESSING THE EFFICACY AND SAFETY OF ETANERCEPT IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

G. Raghu, K. Brown, J. Lasky, 2005 .

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

G. Raghu, R. D. du Bois, K. Brown, 2008, American journal of respiratory and critical care medicine.

PULMONARY, SLEEP, AND CRITICAL CARE UPDATE Update in Interstitial Lung Disease 2020

C. Ryerson, J. Lasky, O. Eickelberg, 2021 .

Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor.

J. Lasky, G. Morris, J. Y. Liu, 1999, The American journal of pathology.

Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis

J. Lasky, C. Feghali-Bostwick, Cecilia G. Sanchez, 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo

Y. Zhuang, J. Lasky, B. Shan, 2014, Respiratory Research.

Histone Deacetylase 6 Regulates TGF-β1–mediated Epithelial–Mesenchymal Transition

J. Lasky, B. Shan, Ying Zhuo, 2012 .

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ILOPROST INHALATION IN ADULTS WITH ABNORMAL PULMONARY ARTERIAL PRESSURE AND EXERCISE LIMITATION ASSOCIATED WITH IDIOPATHIC PULMONARY FIBROSIS

A. Frost, J. Lasky, M. Glassberg, 2007 .

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

G. Criner, L. Richeldi, J. Lasky, 2020, Advances in Therapy.

Using Bronchoscopic Lung Cryobiopsy and a Genomic Classi ﬁ er in the Multidisciplinary Diagnosis of Diffuse Interstitial Lung Diseases

G. Berry, J. Lasky, F. Kheir, 2022 .

Hypercoagulability in ICU Patients With Coronavirus Disease 2019 With Respiratory Failure Results in Increased Prevalence of Venous Thromboembolic Disease

J. Palomino, J. Lasky, J. Caridi, 2020, Chest.

The Pathobiology of Asbestos‐Induced Lung Disease: A Proposed Role for Macrophage‐Derived Growth Factors

J. Lasky, A. Brody, J. Bonner, 1991, Annals of the New York Academy of Sciences.

Epstein - Barr virus latent membrane protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies

J. Lasky, B. Shan, E. Flemington, 2011, Virology Journal.

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells

J. Lasky, E. Flemington, Qinyan Yin, 2017, Virology Journal.

Methylation status and AP1 elements are involved in EBV-mediated miR-155 expression in EBV positive lymphoma cells.

J. Lasky, E. Flemington, Qinyan Yin, 2016, Virology.

A novel murine PDGF-D splicing variant results in significant differences in peptide expression and function.

J. Lasky, G. Morris, Ying Zhuo, 2003, Biochemical and biophysical research communications.

Phenytoin-Associated Granulomatous Pulmonary Vasculitis.

J. Lasky, F. Kheir, P. Daroca, 2016, American journal of therapeutics.

Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin.

A. Mai, J. Lasky, B. Shan, 2011, Biochemical and biophysical research communications.

Requirement of a novel splicing variant of human histone deacetylase 6 for TGF-beta1-mediated gene activation.

Y. Zhuang, J. Lasky, B. Shan, 2010, Biochemical and biophysical research communications.

Requirement of HDAC6 for activation of Notch1 by TGF-β1

Y. Zhuang, J. Lasky, B. Shan, 2016, Scientific Reports.

Dexamethasone activates expression of the receptor and induces lung ﬁbroblast proliferation

J. Lasky, A. Brody, M. Corti, 1998 .

Reversible binding of platelet-derived growth factor-AA, -AB, and -BB isoforms to a similar site on the "slow" and "fast" conformations of alpha 2-macroglobulin.

J. Lasky, A. L. Goodell, J. Bonner, 1992, The Journal of biological chemistry.

Overexpression of Sulf 2 in idiopathic pulmonary fi brosis

J. Lasky, X. Yue, Mark D. Sides, 2013 .

Transcriptome Analysis of Desquamative Interstitial Pneumonia (DIP)

Yao-Zhong Liu, Y. Kondoh, J. Lasky, 2019 .

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

J. Lasky, D. Welsh, D. Prockop, 2011, Stem Cell Research & Therapy.

PDGF-β receptor expression and ventilatory acclimatization to hypoxia in the rat

D. Gozal, J. Lasky, N. Simakajornboon, 2000 .

Brainstem Activation of Platelet‐Derived Growth Factor‐β Receptor Modulates the Late Phase of the Hypoxic Ventilatory Response

D. Gozal, J. Lasky, N. Simakajornboon, 2000, Journal of neurochemistry.

PDGF-beta receptor expression and ventilatory acclimatization to hypoxia in the rat.

D. Gozal, J. Lasky, N. Simakajornboon, 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis.

M. Selman, A. Pardo, J. Lasky, 2001, American journal of respiratory and critical care medicine.

Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells

J. Lasky, C. Morris, L. Myatt, 2007, Virology Journal.

Cyclin-dependent Kinase 9 Is Required for Tumor Necrosis Factor-α-stimulated Matrix Metalloproteinase-9 Expression in Human Lung Adenocarcinoma Cells*

Dawn R. Chin, J. Lasky, B. Shan, 2005, Journal of Biological Chemistry.

Overexpression of Sulf2 in idiopathic pulmonary fibrosis.

J. Lasky, X. Yue, Xinping Yue, 2013, Glycobiology.

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Kevin J Anstrom, K. Anstrom, F. Martinez, 2012, The New England journal of medicine.

Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis.

J. Lasky, A. Brody, D. Prockop, 2007, American journal of respiratory and critical care medicine.

Interstitial fibrosis and growth factors.

J. Lasky, A. Brody, Joseph A. Lasky, 2000, Environmental health perspectives.

Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes

H. Collard, F. Martinez, I. Noth, 2019, Scientific Reports.

Inhibition of HDAC6 Attenuates Tumor Growth of Non-Small Cell Lung Cancer

Y. Zhuang, J. Lasky, B. Shan, 2019, Translational oncology.

Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones.

J. Lasky, D. Mondal, M. Hamblin, 2013, The Ochsner journal.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Hyun J. Kim, I. Noth, M. Strek, 2020, BMC Pulmonary Medicine.

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis

F. Spertini, D. Furst, P. Emery, 2019, Arthritis & rheumatology.

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

F. Martinez, I. Noth, G. Raghu, 2022, BMC pulmonary medicine.

Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation.

J. Lasky, A. Brody, M. Corti, 1998, American Journal of Physiology.

Thy-1 Attenuates TNF-α-Activated Gene Expression in Mouse Embryonic Fibroblasts via Src Family Kinase

J. Lasky, B. Shan, G. Morris, 2010, PloS one.

Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.

Dawn R. Chin, J. Lasky, B. Shan, 2005, The Journal of biological chemistry.

Differential expression, surface binding, and response to connective tissue growth factor in lung fibroblast subpopulations.

J. Lasky, J. Hagood, P. Segarini, 2001, Chest.

Differential expression of platelet-derived growth factor-alpha receptor by Thy-1(-) and Thy-1(+) lung fibroblasts.

J. Lasky, J. Hagood, G. Fuller, 1999, The American journal of physiology.

The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.

G. Kennedy, M. Kreuter, M. Scholand, 2021, Annals of the American Thoracic Society.

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Hyun J. Kim, M. Strek, K. Flaherty, 2022, Respiratory Research.

Over-expression of PDGF-C using a lung specific promoter results in abnormal lung development

J. Lasky, B. Shan, Ying Zhuo, 2006, Transgenic Research.

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib

B. Southern, J. Lasky, J. Belperio, 2021, Clinical medicine insights. Circulatory, respiratory and pulmonary medicine.

Interstitial lung disease progression after genomic usual interstitial pneumonia testing

J. Lasky, R. Harper, F. Kheir, 2022, European Respiratory Journal.

Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF).

Y. Kondoh, J. Lasky, J. Kolls, 2019, Journal of thoracic disease.

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry

Hyun J. Kim, I. Noth, M. Strek, 2019, Respiratory Research.

Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis

Yao-Zhong Liu, J. Lasky, J. Kolls, 2022, medRxiv.

Update in Interstitial Lung Disease 2020.

C. Ryerson, J. Lasky, O. Eickelberg, 2021, American journal of respiratory and critical care medicine.

BMI is Associated with Coronavirus Disease 2019 Intensive Care Unit Admission in African Americans

J. Lefante, J. Lasky, V. Fonseca, 2020, Obesity.

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells

J. Lasky, E. Flemington, Qinyan Yin, 2017, Virology Journal.

The Antiretroviral Agent Nelfinavir Mesylate

J. Lasky, D. Mondal, Taylor T Fuselier, 2017, Arthritis & rheumatology.

Regulatory effects of IL‐15 on allergen‐induced airway obstruction

A. Verma, J. Lasky, M. Manohar, 2017, The Journal of allergy and clinical immunology.

Acute exacerbations of idiopathic pulmonary fibrosis.

H. Collard, I. Noth, G. Raghu, 2007, American journal of respiratory and critical care medicine.

Radial Endobronchial Ultrasound-guided Transbronchial Cryobiopsy

J. Lasky, F. Kheir, U. Kaphle, 2019, Journal of Bronchology & Interventional Pulmonology.

Employing Bronchoscopic Lung Cryobiopsy and a Genomic Classifier in the Multidisciplinary Diagnosis of Diffuse Interstitial Lung Diseases.

G. Berry, J. Lasky, F. Kheir, 2019, Chest.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

in Acute Lung Injury and Pulmonary Fibrosis TGF- (cid:2) 1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung ﬁbroblasts

J. Lasky, Weichao Guo, Fayong Luo, 2017 .

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

J. Lasky, D. Welsh, D. Prockop, 2011, Stem Cell Research & Therapy.

Requirement of HDAC 6 for Transforming Growth Factor-1-induced Epithelial-Mesenchymal Transition *

J. Lasky, B. Shan, Ying Zhuo, 2008 .

NOTCH-ing up Surface Tension in the Fibrotic Lung

J. Lasky, V. Thannickal, 2022, American journal of respiratory and critical care medicine.

Differential expression of platelet-derived growth factor- a receptor by Thy-1 2 and Thy-1 1 lung ﬁbroblasts

J. Lasky, J. Hagood, G. Fuller, 1999 .

Differential expression of platelet-derived growth factor- a receptor by Thy-1 2 and Thy-1 1 lung ﬁbroblasts

J. Lasky, J. Hagood, G. Fuller, 1999 .

Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo.

Dawn R. Chin, J. Lasky, Hong T. Nguyen, 2008, The Journal of biological chemistry.

Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension

J. Lasky, D. Prockop, Mandolin J. Whitney, 2008, The FASEB Journal.

Establishment of Murine Lung Alveolar Epithelial Cell Lines from Lung Tumors Initiated by Somatic Activation of the K-ras Oncogene.

J. Lasky, B. Shan, G. Morris, 2009, ATS 2009.